Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China · Delayed Price · Currency is CNY 12.77
-0.18 (-1.39%)
Jul 22, 2025, 2:45 PM CST
SHA:603439 Market Cap
SHA:603439 has a market cap or net worth of 5.21 billion as of July 22, 2025. Its market cap has increased by 3.82% in one year.
Market Cap
5.21B
Enterprise Value
5.60B
Revenue
2.13B
Ranking
n/a
PE Ratio
20.62
Stock Price
12.77
Market Cap Chart
Since April 28, 2020, SHA:603439's market cap has increased from 4.31B to 5.21B, an increase of 20.78%. That is a compound annual growth rate of 3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2025 | 5.21B | 0.00% |
| Dec 31, 2024 | 5.20B | -32.74% |
| Dec 29, 2023 | 7.74B | 37.27% |
| Dec 30, 2022 | 5.64B | -13.05% |
| Dec 31, 2021 | 6.48B | -21.44% |
| Dec 31, 2020 | 8.25B | 91.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 386.85B |
| Shenzhen Mindray Bio-Medical Electronics | 273.07B |
| WuXi AppTec | 236.49B |
| Sichuan Biokin Pharmaceutical | 128.74B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.04B |
| Aier Eye Hospital Group | 116.29B |
| Shanghai United Imaging Healthcare | 104.88B |
| Yunnan Baiyao Group Co.,Ltd | 100.33B |